Skandinaviska Enskilda Banken (SEB)
EPIX

Skandinaviska Enskilda Banken (SEB)’s ESSA Pharma EPIX Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-51,973
Closed -$9.93K – 750
2025
Q3 		$9.93K Buy
+51,973
New +$62.3K ﹤0.01% 775

Skandinaviska Enskilda Banken (SEB)'s EPIX Position: Q4 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of ESSA Pharma (EPIX) in Q4 2025, closing a stake of 51,973 shares — an estimated $9.93K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in EPIX in Q3 2025 and held it in 1 quarter. The position peaked at $9.93K in Q3 2025. 0 funds tracked by Wall St. Rank hold EPIX as of Q4 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining ESSA Pharma position as of Q4 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 51,973 ESSA Pharma shares in Q4 2025, an estimated $9.93K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in ESSA Pharma in Q3 2025 and held it in 1 quarter.
  • Skandinaviska Enskilda Banken (SEB)'s ESSA Pharma position peaked at $9.93K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2025, filed 12 Feb 2026.